R & D Partners Axis

Learn more about careers, hiring and the staffing industry here.

BioScience Forum

Abstract Machine learning tools promise to revolutionize drug discovery, greatly expand the set of druggable targets, and have shown unbelievably good performance on benchmarks for medicinal chemistry tasks. Unfortunately, recent analyses imply that such apparently-encouraging algorithmic performance is likely to be an artifact of weaknesses in the design of these benchmarks. Therefore, Atomwise is running…

Categories: News

FDA Approves First Targeted Therapy to Treat Patients with Painful Complication of Sickle Cell Disease

FDA approves first targeted therapy to treat patients with painful complication of sickle cell disease

VIA: https://www.worldpharmanews.com/fda/5020-fda-approves-first-targeted-therapy-to-treat-patients-with-painful-complication-of-sickle-cell-disease Today, the U.S. Food and Drug Administration approved Adakveo (crizanlizumab-tmca), a treatment to reduce the frequency of vaso-occlusive crisis – a common and painful complication of sickle cell disease that occurs when blood circulation is obstructed by sickled red blood cells – for patients age 16 years and older. “Hope has never been… Tags: , , ,

Categories: News

3 ways 3D Printed Synthetic Body Parts are Transforming Medical Device Companies

3D Printed Synthetic Tissue and Bone is Here to Stay

VIA – https://www.cadimensions.com/blog/3-ways-3d-printed-synthetic-body-parts-are-transforming-medical-device-companies Written by: Adam Fasnacht l Published in: 3D Printers If you work at a medical device company, you know that there are many situations that require using human body parts. More often than not, these come from cadavers and not 3D printed synthetic tissue. As gross as it may be (and trust me, I’m…

Categories: News

Roche Drug for Spinal Muscular Atrophy Hits Target in Late-Stage Trial

Roche Drug for Spinal Muscular Atrophy

VIA: https://www.reuters.com/article/us-roche-risdiplam-approval/roche-drug-for-spinal-muscular-atrophy-hits-target-in-late-stage-trial-idUSKBN1XL1WL   ZURICH (Reuters) – Roche’s bid to rival Biogen and Novartis in treating spinal muscular atrophy (SMA) got a lift on Monday when the Swiss drugmaker said its drug risdiplam improved motor function in a key study. Roche, which plans to seek approval for the investigational medicine this year, said its SUNFISH trial… Tags: , , , , ,

Categories: News

4 Steps to Position Yourself for a Career Change

Career Change

VIA: https://www.biospace.com/article/how-to-position-yourself-for-a-career-change Published: Nov 05, 2019 By Porschia Parker   Have you ever made a career change? If so, how did it go? Most life sciences professionals are overwhelmed by the thought of making a career transition. Any type of change, whether it be to a new industry or a new position within the same industry,…

Categories: Tips & Tricks

Google Buys Fitbit For $2.1B, Stepping Back Into Wearables

Fitbit

VIA: https://www.fiercebiotech.com/medtech/google-shells-out-2-1b-for-fitbit-and-its-health-focused-wearables – by Conor Hale | Nov 1, 2019   Google has moved to acquire Fitbit through a $2.1 billion deal that will subsume the company’s activity and fitness trackers along with its health-logging platform. The tech giant described the deal as an opportunity to “invest even more in Wear OS”—Google’s software ecosystem for Android-powered smartwatches, which… Tags:

Categories: News

Pi Day

Happy Pi Day   Click Play to see how Emma Haruka Iwao, an employee at Google has broken the Guinness world record for calculating the most digits of Pi. The previous record was set in 2016 of 22.4 trillion digits, yes TRILLION. Emma and a team at Google computed Pi to 31.4 trillion decimal place…. Read more »

BioScience Forum Presents

Nathalie Dubois-Stringfellow

R&D Partners is excited to attend the BioScience Forum, volunteering monthly at the networking and presentation event. This month Nathalie Dubois-Stringfellow, Ph.D. Vice President, Product Development and Management Sangamo Therapeutics is presenting on “Genomic Medicines: Applications in CNS and Autoimmunity“ When: February 27th, 6:00 PM – 9:00 PM Where: 275 S Airport Blvd, South San…

Categories: News